DNAPrint Genomics

DNAPrint Genomics Independent Investors Information DNA DNAG
DNAPrint Genomics DNA Fingerprinting This Site is Not Owned by DNAPrint    Sarasota Florida


DnapInvestor Home
Archived Articles
Current Stock Charts
DNAPrint Summary
Contact Us

Dnaprint Genomics DNA Helix









New Stock Name: DNAG
Latest Press Release
Latest News Article
Latest Multi-Media
DnaPrint.com
AncestryByDNA.com
DNAWitness.net
More DNAP Sites/Forums


To launch Level II Applet click here.

From DNAPrint.com:
DNAPrintTM genomics, Inc. is a genomics science company focused on the sale of unique proprietary genetic testing
Products and services. The Company's core patented and proprietary technologies for efficiently targeting single nucleotide polymorphisms ("SNPs") enable us to provide novel predictive genetic tests at a significant cost advantage over our competitors. DnaPrint.com


 LATEST NEWS ARTICLE:
  • SEC Reports here.
  • DNAPrint Website Press Releases

  •     June 26, 2006

    bellwetherreport.com: The Bellwether Report Updates Investors on the recent announcements surrouding DNAPrint Genomics, Inc


    By M2
    Last Update: 6/26/2006 4:03:26 AM Data provided by

    Jun 26, 2006 (M2 PRESSWIRE via COMTEX) -- DNAPrint Genomics, Inc. (DNAG), is a company that our research team will be tracking over the ensuing weeks. They recently came out with a significant corporate development, causing a market stir. The BWR Research Team will continue to bring its subscribers cutting edge research tools, and second to none customer service.

    DNAPrint Genomics, Inc developer of genomics-based products and services in two primary markets: biomedical and forensics, this morning announced that Jason Eshleman, Ph.D., Senior Research Director at the Company's Trace Genetics subsidiary, is a scheduled guest lecturer for today's session of a course titled "Genetics Law and Society" offered by the California Department of Justice.

    The two-day course, which began on Thursday, was organized by the California Criminalistics Institute, a unit of the California Department of Justice, Bureau of Forensic Services, and is being held at its DNA laboratories in Richmond, Calif.

    "Phenotype Profiling," the topic of Dr. Eshleman's lecture, addresses issues related to genetic typing, ancestry, and the scientific basis for the Company's DNAWitness(TM) forensics technology for law enforcement. His lecture is part of a seminar designed to offer an introduction to the legal, societal, and bioethical issues that arise as a result of advances in genetics.

    "We are pleased that Dr. Eshleman was chosen to participate in this course," said DNAPrint President and Chief Executive Officer Richard Gabriel. "Our DNAWitness technology is utilized by California authorities in a number of criminal investigations. We are pleased that DNAWitness is being used in the course as an example of current DNA technology and its potential for law enforcement."

    "Genetics, Law and Society" provides an introduction to the legal, societal, and bioethical issues that arise from advances in genetics. Major topic areas include: advances in forensic genetics, genetic privacy and databanks, and selected applications in medical genetics. It is intended for criminal justice professionals who use DNA to solve crimes, including forensic scientists, criminalists, laboratory managers and other crime laboratory personnel.

    Earlier this week the company released an exciting new innovative new program that will enable dentists to offer DNA testing to patients who want to explore their family heritage.

    AncestrybyDNA(TM) test kits and marketing materials will be made available to participating dentists who will be able to provide DNA sampling in a hygienic environment. Once the samples have been taken with a mouth swab, the dentists will forward them to DNAPrint for analysis. Confidential test results will be sent directly to patients from DNAPrint laboratories.

    "We believe the professional, safe and trusted environments of dentists' offices lend themselves perfectly to DNA sampling and test result confidence," said DNAPrint President and Chief Executive Officer Richard Gabriel. "We hope this program encourages individuals to explore their family histories through genetic testing."

    Following these announcements shares of DNAPrint Genomics, Inc traded fairly flat, as they were bounced back and forth between $0.017 and $0.018, a level in which it has traded for quite sometime. I feel that this company has a lot of potential as they have a strong management team who have the experience and knowledge to help carry this company forward through to the future. The BWR Research Team will continue to track the developments surrounding DNAPrint Genomics, Incand many other exciting companies.

    To review research on small cap companies DNAPrint Genomics, Inc, as well as many more exciting articles we encourage you to visit www.bellwetherreport.com. You can find these reports under the "Today's Articles" section. No credit Card Needed!!

    The Bellwether Report will continue to research all of the markets to bring you exciting opportunities!! If you are interested in receiving more information on these small or large cap opportunities as well as other features of our site, feel free to sign up for a complimentary subscription to the #1 online investment tool www.bellwetherreport.com.

    Companies looking to advertise with Bellwether Report should email jlee@bellwetherreport.com with the subject line (Advertising).

    All material herein was prepared by the Bellwetherreport.com, (Bellwether) based upon information believed to be reliable. The information contained herein is not guaranteed by Bellwether to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

    This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Bellwether is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

    Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Bellwether may receive compensation in cash or shares from independent third parties or from the companies mentioned.

    Bellwether's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value.

    Bellwether will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

    This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

    You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Bellwether undertakes no obligation to update such statements.

    M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

    LATEST NEWS:
    GoTo See New Articles Archives



    Dnaprint AncestryByDNA Information Site by Independent Investors. DNA Fingerprinting and Testing by DnaPrint Genomics specialize in complex genetic analytics and information resource products for next generations personalized medicine.

    Genotyping, sequencing fingerprinting, testing snp discovery pharmacogenomics personalized medicine forensics eye color, investigative tool DNA DNA print. genomics, polymorphism informatics genome, SNP nucleotide, human artificial intelligence phenomics neural, net pattern, cancer mathematics modeling disease Ancestry familytree dna fingerprint migration chromosome paternal maternal genome bioscience informatics lineage dna print dnaprint.



    © 2004-6 This page is put together by
    Private Independent Investors


    Please Visit:
    DNAPrint Genomics
    900 Cocoanut Ave.
    Sarasota, FL 34236
    (941) 366-3400

    Dnapinvestor Home

    DNAPRINT Genomics Press Release